Like a Bolt from the Blue: Phthalocyanines in Biomedical Optics

The purpose of this review is to compile preclinical and clinical results on phthalocyanines (Pcs) as photosensitizers (PS) for Photodynamic Therapy (PDT) and contrast agents for fluorescence imaging. Indeed, Pcs are excellent candidates in these fields due to their strong absorbance in the NIR region and high chemical and photo-stability. In particular, this is mostly relevant for their in vivo activation in deeper tissular regions. However, most Pcs present two major limitations, i.e., a strong tendency to aggregate and a low water-solubility. In order to overcome these issues, both chemical tuning and pharmaceutical formulation combined with tumor targeting strategies were applied. These aspects will be developed in this review for the most extensively studied Pcs during the last 25 years, i.e., aluminium-, zinc- and silicon-based Pcs.


Published in:
Molecules, 17, 98-144
Year:
2012
Publisher:
Molecular Diversity Preservation International
ISSN:
1420-3049
Keywords:
Laboratories:




 Record created 2012-03-01, last modified 2018-01-28


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)